Hisatoshi Sugiura
Overview
Explore the profile of Hisatoshi Sugiura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
1697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narita D, Hishinuma E, Ebina-Shibuya R, Miyauchi E, Matsukawa N, Motoike I, et al.
Lung Cancer
. 2025 Jan;
200:108082.
PMID: 39884221
Background: Lung cancer is the deadliest disease globally, with more than 120,000 diagnosed cases and more than 75,000 deaths annually in Japan. Several treatment options for advanced lung cancer are...
2.
Nomura N, Matsumoto H, Asano K, Hayashi Y, Yokoyama A, Nishimura Y, et al.
J Allergy Clin Immunol Glob
. 2024 Dec;
4(1):100364.
PMID: 39659740
Background: Sensitization to mucus plugs, and bacterial colonization may coexist and relate to a refractory phenotype during follow-up in asthma with bronchiectasis and allergic bronchopulmonary aspergillosis (ABPA). Objective: This study...
3.
Miyadera K, Kakuto S, Sugai M, Tsugitomi R, Amino Y, Uchibori K, et al.
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518151
A prognostic marker in patients with non-small-cell lung cancer (NSCLC) treated with anti-PD-1/PD-L1 antibodies must be established. This study explored serum cytokeratin fraction 21-1 (CYFRA 21-1), which represents a squamous...
4.
Fujino N, Yamada M, Saito T, Konno S, Sugiura H
Am J Respir Cell Mol Biol
. 2024 Sep;
71(5):621-622.
PMID: 39226578
No abstract available.
5.
Muro S, Kawayama T, Sugiura H, Seki M, Duncan E, Bowen K, et al.
Respir Res
. 2024 Aug;
25(1):297.
PMID: 39103901
Background: Japanese guidelines recommend triple inhaled corticosteroid (ICS)/long-acting muscarinic antagonist (LAMA)/long-acting β-agonist (LABA) therapy in patients with chronic obstructive pulmonary disease (COPD) and no concurrent asthma diagnosis who experience frequent...
6.
Ono Y, Fujino N, Saito T, Matsumoto S, Konno S, Endo T, et al.
Respir Investig
. 2024 Jul;
62(5):856-866.
PMID: 39068895
Background: Monocytes play a crucial role in innate immune responses for host defense, however, their involvement in chronic obstructive pulmonary disease (COPD) remains poorly understood. We previously identified a subset...
7.
Gon Y, Sorimachi R, Yoshida Y, Tamai Y, Takashima I, Arita Y, et al.
Adv Ther
. 2024 Jul;
41(9):3585-3597.
PMID: 39046695
Introduction: Symptom status and treatment changes among patients with chronic obstructive pulmonary disease (COPD) using inhaler treatment in real-world clinical settings are not well understood, particularly according to class of...
8.
Horino S, Ozaki A, Yamaguchi Y, Miyabayashi H, Aki H, Aizawa H, et al.
Arerugi
. 2024 Jul;
73(5):399-405.
PMID: 39010199
Background: The number of students with food allergies is on the increase, while the problems and burdens of school teachers and staff are not yet clear. Our study was designed...
9.
Yamada M, Takase M, Nakaya K, Nakamura T, Kogure M, Nakaya N, et al.
J Allergy Clin Immunol Glob
. 2024 May;
3(3):100253.
PMID: 38745867
Background: Measurement of fractional exhaled nitric oxide (Feno) has been used in the diagnosis and management of asthma. Understanding the distribution of Feno in a larger resident population and its...
10.
Ono Y, Tode N, Yamamoto Y, Iwasaki C, Konno S, Sugiyama H, et al.
Intern Med
. 2024 May;
63(24):3353-3358.
PMID: 38719600
Herein, we report a case of Hermansky-Pudlak syndrome (HPS) in which respiratory symptoms improved with pirfenidone treatment. A 43-year-old Japanese woman with oculocutaneous albinism presented with a cough and dyspnea....